CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, announced the awarding of two new contracts by top-20 pharma companies, which will see the company’s innovative eCOA solutions used to capture patient-reported outcomes in 15 global dermatology trials.
As a leading global player in this field, CRF Health was selected due to its ability to support the large-scale program involving multiple facilities across the US, Europe and Asia Pacific. The trials will include a range of Phase II-IV studies, involving upwards of 200 sites and an average of 600 participants per study, and span more than 170 countries, including more than 250 languages.
In the majority of studies, CRF Health’s TrialMax Touch® handheld patient eDiary and the TrialMax Slate® tablet solutions will be employed to make data collection as efficient and unobtrusive as possible, ensuring rapid and efficient collection of a more complete data set. In addition, CRF Health’s experienced and specialist team will work with the sponsors throughout the studies, providing additional reliability and flexibility, to ensure the trials meet the particularly ambitious timeframes for submission which are in place.
Commenting on the new contracts, Mike Nolte, CEO at CRF Bracket, said, “CRF Health enjoys an established track record with these pharma partners, having previously worked collaboratively to deliver numerous successful trials. These latest contract wins demonstrate growing confidence and trust in our ability to deliver results, and is evidence of the continued strength of those relationships. CRF Health’s experience and proven track record in patient-centered eCOA solutions for dermatology clinical trials make CRF Health ideally placed to deliver these high-profile studies, which will undoubtedly contribute to better treatments for those living with various skin conditions.”
For further information on CRF Health, please visit http://www.crfhealth.com
About CRF Health
CRF Health, a CRF Bracket company, is the leading global provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, the company delivers best in class, fully integrated eSource solutions for pharma partners. Solutions include TrialMax®, an eCOA suite which consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention, and TrialConsent®, the patient-centered, intuitive and interactive informed eConsent suite. Learn more at www.crfhealth.com